Journal
JOURNAL OF ATTENTION DISORDERS
Volume 14, Issue 3, Pages 267-272Publisher
SAGE PUBLICATIONS INC
DOI: 10.1177/1087054709356386
Keywords
ADHD; methylphenidate; prescription prevalence; population study; school-aged children; Switzerland
Categories
Funding
- Public Health Service of the Canton of Vaud, Lausanne/Switzerland
Ask authors/readers for more resources
Objective: Methylphenidate is prescribed for children and adolescents to treat ADHD. As in many Western countries, the increase in methylphenidate consumption is a public concern in Switzerland. The article discusses the authors' assessment of prescription prevalence in 2002 and 2005 for school-aged children in the canton of Vaud. Method: Pharmacy prescription information is available from the regional public health authority. Descriptive analyses are conducted on an anonymized database of the years 2002 and 2005. Data for each year are compared to assess trends in methylphenidate prescription prevalence. Results: The findings show an increase from 0.74% to 1.02% in the number of prescriptions for 5- to 14-year-old children, particularly in prescriptions for girls. Data also show important geographical differences in prescription. Conclusion: The prevalence of methylphenidate prescription is lower in Switzerland than other Western countries, particularly the United States. However, some aspects of prevalence are similar, including the increase per year, demographics, and geographic characteristics.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available